Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Yhdistetyt ravitsemus- ja liikuntasuositukset rintasyöpää sairastaneille naisille

perjantai 2. lokakuuta 2026 päivittänyt: Prof. Dr. Alejandro Martínez-Rodríguez, University of Alicante

Tutkimus ruokavalio-ravitsemusstrategioiden ja liikuntaohjelman toteuttamisen vaikutuksista fyysisellä, fysiologisella ja psykologisella tasolla naisilla, joilla on rintasyövän historia.

This study aims to evaluate the effects of a combined dietary-nutritional and physical exercise intervention on physical, physiological, and psychological outcomes in women who are breast cancer survivors. Participants will be randomly assigned to different intervention groups involving dietary modification, exercise training, or their combination, compared to a control group. The program will last 12 weeks and will include pre- and post-intervention assessments of body composition, metabolic parameters, functional capacity, and quality of life.

The primary goal is to assess improvements in physical fitness, body composition, and emotional well-being, as well as to identify potential synergistic effects of combined interventions in this population.

Tutkimuksen yleiskatsaus

Yksityiskohtainen kuvaus

Breast cancer survivors often experience long-term physical and psychological side effects derived from treatment, such as fatigue, loss of muscle mass, metabolic alterations, and reduced quality of life. Lifestyle interventions involving nutrition and exercise have demonstrated significant potential to mitigate these effects and promote overall recovery.

This randomized controlled clinical trial will include adult female breast cancer survivors who have completed their primary oncological treatment. Participants will be divided into six parallel groups:

  1. Control group - no intervention.
  2. Mediterranean diet group (MD) - individualized nutritional plan based on Mediterranean dietary patterns.
  3. Strength training group (ST) - supervised resistance exercise sessions.
  4. Endurance training group (ET) - supervised aerobic exercise sessions.
  5. Combined training group (CT) - combination of strength and endurance training.
  6. Combined diet and exercise group (MD+CT) - simultaneous application of Mediterranean diet and combined training.

The intervention will last 12 weeks, during which participants in the intervention groups will attend supervised sessions and receive continuous nutritional guidance. Assessments will be performed at baseline and after 12 weeks, including anthropometric and body composition analysis, metabolic and inflammatory markers, physical fitness testing, dietary intake, and psychological well-being scales.

This study seeks to identify the most effective strategy-dietary, physical, or combined-for improving health outcomes, functionality, and emotional recovery in breast cancer survivors, contributing to the development of comprehensive post-treatment rehabilitation programs.

Opintotyyppi

Interventio

Ilmoittautuminen (Todellinen)

120

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskelupaikat

    • Alicante
      • Elche, Alicante, Espanja, 03203
        • European Institute Of Exercise and Health

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

30 vuotta - 65 vuotta (Aikuinen, Vanhempi Aikuinen)

Hyväksyy terveitä vapaaehtoisia

Ei

Sukupuolet, jotka voivat opiskella

Nainen

Kuvaus

Inclusion Criteria:

  • Women aged 30 to 65 years.
  • Previous diagnosis of breast cancer (stages I-III) confirmed by medical records.
  • Completion of primary oncological treatment (surgery, radiotherapy, chemotherapy, and/or hormone therapy) at least 3 months before enrollment.
  • Absence of active cancer or evidence of recurrence.
  • Medical clearance to perform physical exercise.
  • Willingness to participate in dietary and/or exercise interventions for 12 weeks.
  • Ability to attend evaluation and intervention sessions and comply with study procedures.
  • Signed written informed consent.

Exclusion Criteria:

  • Active cancer, metastasis, or ongoing chemotherapy or radiotherapy.
  • Severe cardiovascular, respiratory, renal, hepatic, or metabolic disease that contraindicates exercise.
  • Musculoskeletal or neurological conditions limiting participation in physical activity.
  • Severe psychiatric disorders or cognitive impairment affecting adherence to the intervention.
  • Current participation in another clinical trial or structured lifestyle intervention.
  • Use of dietary supplements, appetite regulators, or pharmacological agents affecting metabolism during the study period.
  • Pregnancy, breastfeeding, or intention to become pregnant during the study.
  • Inability to comply with the intervention schedule or follow-up assessments.

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Hoito
  • Jako: Satunnaistettu
  • Inventiomalli: Rinnakkaistehtävä
  • Naamiointi: Yksittäinen

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Ei väliintuloa: Arm 1 - Control Group

Participants will not receive any specific dietary or exercise intervention. They will be asked to maintain their usual lifestyle and dietary habits during the 12-week study period. General health recommendations based on national guidelines will be provided at baseline.

Kokeellinen: Arm 2 - Mediterranean Diet Group (MD)

Participants will receive individualized nutritional counseling promoting adherence to a Mediterranean dietary pattern, emphasizing fruits, vegetables, legumes, whole grains, olive oil, nuts, fish, and moderate dairy intake. Processed and high-sugar foods will be limited. Dietitians will provide personalized follow-up and adjustments every two weeks to ensure adherence.

Individualized nutritional counseling based on Mediterranean diet principles, emphasizing the intake of fruits, vegetables, legumes, whole grains, nuts, olive oil, and fish, while reducing red meat, processed foods, and added sugars. Sessions will be held biweekly to ensure adherence and promote long-term dietary behavior change.

Kokeellinen: Arm 3 - Strength Training Group (ST)

Participants will perform a 12-week supervised resistance training program focused on improving muscular strength and functional capacity. Sessions will be conducted three times per week, lasting approximately 60 minutes, and include major muscle groups using elastic bands, free weights, and bodyweight exercises. Training load will progressively increase according to individual capacity.

A structured resistance exercise program performed three times per week for 12 weeks. Each 60-minute session will include exercises for major muscle groups using elastic bands, dumbbells, or body weight, progressively increasing intensity to improve muscle strength and endurance.

Kokeellinen: Arm 4 - Endurance Training Group (ET)

Participants will follow a structured aerobic exercise program consisting of walking, cycling, or treadmill sessions three times per week for 12 weeks. The intensity will be moderate (60-75% of estimated maximal heart rate), gradually progressing as tolerated. The goal is to enhance cardiorespiratory fitness and overall endurance.

A structured aerobic exercise program consisting of walking, cycling, or treadmill training three times per week for 12 weeks. Exercise intensity will range from 60% to 75% of the estimated maximal heart rate, progressively adjusted to enhance cardiovascular fitness and fatigue resistance.

Kokeellinen: Arm 5 - Combined Training Group (CT)

Participants will perform both strength and aerobic training during the 12-week intervention. Each session (3 per week, 60-70 minutes) will include resistance exercises targeting major muscle groups followed by aerobic activity at moderate intensity. The program aims to improve both muscular and cardiovascular performance synergistically.

A combined exercise protocol including both resistance and aerobic components within each 60-70-minute session, three times per week for 12 weeks. Strength exercises will precede moderate-intensity aerobic work to improve overall physical performance and functional capacity.

Kokeellinen: Arm 6 - Mediterranean Diet plus Combined Training Group (MD+CT)

Participants will simultaneously receive the Mediterranean Diet counseling and participate in the Combined Training program for 12 weeks. The objective is to assess the synergistic effects of diet and exercise on physical, physiological, and psychological health in breast cancer survivors.

Comprehensive lifestyle intervention combining Mediterranean diet counseling with the supervised combined training program. Participants will receive individualized diet plans and attend three supervised exercise sessions per week. The intervention targets improvements in body composition, physical fitness, and emotional well-being.

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Change in Fat-Free Mass (kg)
Aikaikkuna: Baseline and Week 12

To evaluate changes in fat-free mass after the 12-week intervention, measured by bioimpedance analysis (BIODY XPERT ZM).

Baseline and Week 12

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Change in Fat Mass (%)
Aikaikkuna: Baseline and Week 12

To assess changes in total body fat percentage using bioimpedance analysis.

Baseline and Week 12
Change in Body Weight (kg)
Aikaikkuna: Baseline and Week 12

To determine body weight variation during the 12-week intervention.

Baseline and Week 12
Change in Body Mass Index (kg/m²)
Aikaikkuna: Baseline and Week 12

To evaluate changes in BMI calculated as weight divided by height squared.

Baseline and Week 12
Change in Waist Circumference (cm)
Aikaikkuna: Baseline and Week 12

To assess central adiposity changes by measuring waist circumference.

Baseline and Week 12
Change in Handgrip Strength (kg)
Aikaikkuna: Baseline and Week 12

To evaluate upper-body muscular strength using a digital hand dynamometer.

Baseline and Week 12
Change in Lower-Limb Strength (kg)
Aikaikkuna: Baseline and Week 12

To assess lower-limb strength through isometric tests using a load cell or force platform.

Baseline and Week 12
Change in Functional Capacity (6-Minute Walk Test Distance, m)
Aikaikkuna: Baseline and Week 12

To evaluate cardiorespiratory endurance using the 6-minute walk test.

Baseline and Week 12
Change in Balance Performance
Aikaikkuna: Baseline and Week 12

To assess dynamic balance and postural control

Baseline and Week 12
Change in Flexibility (Sit-and-Reach Test, cm)
Aikaikkuna: Baseline and Week 12

To evaluate flexibility of the posterior chain through the sit-and-reach test.

Baseline and Week 12
Change in Maximal Oxygen Uptake (VO₂max, mL/kg/min)
Aikaikkuna: Baseline and Week 12

To determine changes in aerobic capacity using an incremental treadmill test with indirect calorimetry (METALYZ-ERR 3 B-R3 spirometer).

Baseline and Week 12
Change in Total Cholesterol (mg/dL)
Aikaikkuna: Baseline and Week 12

To evaluate lipid profile variations by measuring total cholesterol concentration.

Baseline and Week 12
Change in HDL Cholesterol (mg/dL)
Aikaikkuna: Baseline and Week 12

To assess cardioprotective lipid changes.

Baseline and Week 12
Change in LDL Cholesterol (mg/dL)
Aikaikkuna: Baseline and Week 12

To measure changes in LDL cholesterol levels.

Baseline and Week 12
Change in Triglycerides (mg/dL)
Aikaikkuna: Baseline and Week 12

To determine variations in triglyceride concentration.

Baseline and Week 12
Change in Fasting Glucose (mg/dL)
Aikaikkuna: Baseline and Week 12

To assess metabolic health by measuring fasting plasma glucose.

Baseline and Week 12
Change in C-Reactive Protein (mg/L)
Aikaikkuna: Baseline and Week 12

To evaluate systemic inflammation using CRP levels.

Baseline and Week 12
Change in Interleukin-6 (pg/mL)
Aikaikkuna: Baseline and Week 12

To measure inflammatory status via IL-6 concentration.

Baseline and Week 12
Change in Fatigue (FACIT-F Questionnaire Score)
Aikaikkuna: Baseline and Week 12

Description: Fatigue will be assessed using the Functional Assessment of Chronic Illness Therapy - Fatigue Scale (FACIT-F). This questionnaire consists of 13 items rated on a 5-point Likert scale ranging from 0 ("not at all") to 4 ("very much"), reflecting fatigue experienced during the past 7 days. The total score is calculated by summing the item scores (after reverse scoring where applicable). Range: 0-52. Interpretation: Higher scores indicate less fatigue and therefore a better functional status, while lower scores reflect greater fatigue severity.

Baseline and Week 12
Change in Sleep Quality (PSQI Total Score)
Aikaikkuna: Baseline and Week 12

Description: Sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI), a 19-item self-reported questionnaire that evaluates sleep quality and disturbances over the previous month. The items are grouped into seven components (subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction), each scored from 0 to 3. The global PSQI score is the sum of the components (range 0-21). Range: 0-21. Interpretation: Higher scores indicate poorer sleep quality.

Baseline and Week 12
Change in Physical Activity Level (IPAQ Total Score)
Aikaikkuna: Baseline and Week 12

Description: Physical activity levels will be evaluated using the International Physical Activity Questionnaire - Short Form (IPAQ-SF), which records the frequency and duration of walking, moderate, and vigorous activities over the past 7 days. The results are expressed as total metabolic equivalent minutes per week (MET-min/week) and can be categorized into three levels: low, moderate, or high activity. Range: 0 to unlimited MET-min/week. Interpretation: Higher scores indicate higher physical activity levels.

Baseline and Week 12
Change in Dietary Adherence (Mediterranean Diet Adherence Screener Score)
Aikaikkuna: Baseline and Week 12

Description: Adherence to the Mediterranean diet will be assessed using the PREDIMED Questionnaire, a validated 14-item questionnaire evaluating key dietary habits such as olive oil use, fruit and vegetable consumption, fish intake, and limitation of red meat and sweets. Each affirmative answer scores 1 point, yielding a total score from 0 (minimal adherence) to 14 (maximal adherence). Range: 0-14. Interpretation: Higher scores indicate better adherence to the Mediterranean dietary pattern.

Baseline and Week 12

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Todellinen)

Perjantai 1. syyskuuta 2023

Ensisijainen valmistuminen (Todellinen)

Keskiviikko 31. joulukuuta 2025

Opintojen valmistuminen (Todellinen)

Tiistai 30. kesäkuuta 2026

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Tiistai 25. marraskuuta 2025

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Maanantai 8. joulukuuta 2025

Ensimmäinen Lähetetty (Todellinen)

Keskiviikko 10. joulukuuta 2025

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Maanantai 5. lokakuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Perjantai 2. lokakuuta 2026

Viimeksi vahvistettu

Sunnuntai 1. helmikuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa